NUMB and chronic myelogenous leukemia, BCR-ABL1 positive: Numb shows tumour-suppressor function and its expression is frequently lost in lymphomas, breast tumours, non-small cell lung carcinomas (NSCLCs), salivary gland carcinoma and chronic myelogenous leukaemia (CML) [59].